Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense.

To further understand the role of cytokine responses in symptom formation and host defenses in influenza infection, we determined the levels of IL-1beta, IL-2, IL-6, IL-8, IFN-alpha, TGF-beta, and TNF-alpha in nasal lavage fluid, plasma, and serum obtained serially from 19 volunteers experimentally infected with influenza A/Texas/36/91 (H1N1) and correlated these levels with various measures of infection and illness severity. We found that IL-6 and IFN-alpha levels in nasal lavage fluids peaked early (day 2) and correlated directly with viral titers, temperature, mucus production, and symptom scores. IL-6 elevations were also found in the circulation at this time point. In contrast, TNF-alpha responses peaked later (day 3 in plasma, day 4 in nasal fluids), when viral shedding and symptoms were subsiding. Similarly, IL-8 peaked late in the illness course (days 4-6) and correlated only with lower respiratory symptoms, which also occurred late. None of IL-1beta, IL-2, or TGF-beta levels increased significantly. These data implicate IL-6 and IFN-alpha as key factors both in symptom formation and host defense in influenza.

[1]  M. Adachi,et al.  Expression of IL-6, IL-8, and RANTES on human bronchial epithelial cells, NCI-H292, induced by influenza virus A. , 1996, The Journal of allergy and clinical immunology.

[2]  M. Kluger,et al.  Cytokines and the acute phase response to influenza virus in mice. , 1995, The American journal of physiology.

[3]  M. Kaliner,et al.  Estimation of nasal epithelial lining fluid using urea as a marker. , 1993, The Journal of allergy and clinical immunology.

[4]  J. Mcghee,et al.  Cytokine profiles of bronchoalveolar lavage cells from mice with influenza pneumonia: consequences of CD4+ and CD8+ T cell depletion. , 1993, Regional immunology.

[5]  C. B. Smith,et al.  Presence of interferon in acute- and convalescent-phase sera of humans with influenza or influenza-like illness of undetermined etiology. , 1982, The Journal of infectious diseases.

[6]  A. Choi,et al.  Influenza virus A infection induces interleukin-8 gene expression in human airway epithelial cells. , 1992, FEBS letters.

[7]  Renegar Kb INFLUENZA VIRUS INFECTIONS AND IMMUNITY : A REVIEW OF HUMAN AND ANIMAL MODELS , 1992 .

[8]  I. Wortman,et al.  Nasal cytokine production in viral acute upper respiratory infection of childhood. , 1995, The Journal of infectious diseases.

[9]  D. Gemsa,et al.  Influenza A virus infection of macrophages. Enhanced tumor necrosis factor-alpha (TNF-alpha) gene expression and lipopolysaccharide-triggered TNF-alpha release. , 1991, Journal of immunology.

[10]  J. Orange,et al.  An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. , 1996, Journal of immunology.

[11]  S. Opal,et al.  Characterization of Early Cytokine Responses and an Interleukin (IL)-6–dependent Pathway of Endogenous Glucocorticoid Induction during Murine Cytomegalovirus Infection , 1997, The Journal of experimental medicine.

[12]  P. Marcellin,et al.  Treatment of chronic viral hepatitis. , 1994, Bailliere's clinical gastroenterology.

[13]  J. Van Snick Interleukin-6: an overview. , 1990, Annual review of immunology.

[14]  D. J. Arora,et al.  Stimulation of tumor necrosis factor secretion by purified influenza virus neuraminidase. , 1990, Cellular immunology.

[15]  F. Vacheron,et al.  Production of interleukin 1 and tumour necrosis factor activities in bronchoalveolar washings following infection of mice by influenza virus. , 1990, The Journal of general virology.

[16]  K. B. Renegar Influenza virus infections and immunity: a review of human and animal models. , 1992, Laboratory animal science.

[17]  J. Gray,et al.  Viral Infections , 2010, Small Animal Pediatrics.

[18]  D. Gemsa,et al.  Infection of macrophages by influenza A virus: characteristics of tumour necrosis factor-alpha (TNF alpha) gene expression. , 1996, Research in virology.

[19]  K. Frei,et al.  A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. , 1992, Journal of immunology.

[20]  E. Fikrig,et al.  Interleukin (IL)-6 Directs the Differentiation of IL-4–producing CD4+ T Cells , 1997, The Journal of experimental medicine.

[21]  R. Peper,et al.  Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia. , 1995, Microbial pathogenesis.

[22]  Jie Yang,et al.  Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  D. Gemsa,et al.  Role of macrophage cytokines in influenza A virus infections. , 1993, Immunobiology.

[24]  Weiliang Tang,et al.  Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation. , 1996, The Journal of clinical investigation.

[25]  D. Gemsa,et al.  Infection of macrophages by influenza A virus: characteristics of tumour necrosis factor-α (TNFα) gene expression , 1996 .

[26]  J. Orange,et al.  Interferon-α/β inhibition of interleukin 12 and interferon-γ production in vitro and endogenously during viral infection , 1997 .

[27]  A. Choi,et al.  Influenza virus A infection induces interleukin‐8 gene expression in human airway epitheial cells , 1992 .